SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-208151
Filing Date
2011-08-03
Accepted
2011-08-03 16:08:33
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 480102
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex311.htm EX-31.1 6680
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex312.htm EX-31.2 7017
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex32.htm EX-32 4368
  Complete submission text file 0001193125-11-208151.txt   4559470

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT dndn-20110630.xml EX-101.INS 806061
6 XBRL TAXONOMY EXTENSION SCHEMA dndn-20110630.xsd EX-101.SCH 47308
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dndn-20110630_cal.xml EX-101.CAL 49826
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dndn-20110630_def.xml EX-101.DEF 97125
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dndn-20110630_lab.xml EX-101.LAB 349872
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dndn-20110630_pre.xml EX-101.PRE 253572
Mailing Address
Business Address 3005 FIRST AVENUE SEATTLE WA 98121 206254545
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30681 | Film No.: 111007060
SIC: 2834 Pharmaceutical Preparations